I(f) blocking potency of ivabradine is preserved under elevated endotoxin levels in human atrial myocytes

Lower heart rate is associated with better survival in patients with multiple organ dysfunction syndrome (MODS), a disease mostly caused by sepsis. The benefits of heart rate reduction by ivabradine during MODS are currently being investigated in the MODI(f)Y clinical trial. Ivabradine is a selectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Scheruebel, Susanne, Koyani, Chintan N., Hallström, Seth, Lang, Petra, Platzer, Dieter, Mächler, Heinrich, Lohner, Karl, Malle, Ernst, Zorn-Pauly, Klaus, Pelzmann, Brigitte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academic Press 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046244/
https://www.ncbi.nlm.nih.gov/pubmed/24583250
http://dx.doi.org/10.1016/j.yjmcc.2014.02.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046244/
https://www.ncbi.nlm.nih.gov/pubmed/24583250
http://dx.doi.org/10.1016/j.yjmcc.2014.02.010

Ejemplares similares